Julphar’s Chairman and Vice-Chairman Step Down
Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa has announced the resignations of the Chairman and Vice-Chairman of its Board of Directors.
His Highness Sheikh Faisal Bin Saqr Al Qasimi, has been Julphar’s Chairman for the past 13 years while Sheikh Abdullah Bin Faisal Al Qasimi was the company’s Vice-chairman for the last 2 years.
His Highness Sheikh Faisal was responsible for the strategic development and direction of Julphar and played a vital role in furthering the company’s business interests in the region and internationally.
Under his leadership, the company launched many successful products in key therapeutic areas and markets and became the number 1 pharmaceutical manufacturer in the UAE in 2018. In 2012, Julphar began biosimilars production and became one of the world’s leading producers of insulin thanks to its state-of-the art biotechnology facility.
The past decade has also seen the launch of Julphar’s consumer division, Julphar Life, and the opening of manufacturing facilities in Ethiopia, Bangladesh and more recently, Saudi Arabia.
Jerome Carle, General Manager of Julphar, said: “It is with deep regret that we announce the resignations of His Highness Sheikh Faisal and Sheikh Abdullah.
“Under His Highness’s strong leadership, Julphar has grown and developed considerably. The company became a leader in many key markets.
“I would like to express my sincere gratitude to both His Highness Sheikh Faisal and Sheikh Abdullah, thank them for all their contributions and wish them well in their future endeavors. It goes without saying that they will be sorely missed by everyone at Julphar.”
The resignations were announced ahead of the company’s Annual General Assembly, which has been called to elect five new board members.